
The key reasons why Akebia Therapeutics Inc (AKBA) is -25.96% away from 52-week high?
Akebia Therapeutics Inc (NASDAQ: AKBA) open the trading on Thursday, with a bit cautious approach as it glided -3.21% to $3.02, before settling in for
Akebia Therapeutics Inc (NASDAQ: AKBA) open the trading on Thursday, with a bit cautious approach as it glided -3.21% to $3.02, before settling in for
Akebia Therapeutics Inc (NASDAQ: AKBA) kicked off on Monday, down -5.02% from the previous trading day, before settling in for the closing price of $3.19.
On Monday, Akebia Therapeutics Inc (NASDAQ: AKBA) was -4.31% drop from the session before settling in for the closing price of $3.25. A 52-week range
Akebia Therapeutics Inc (NASDAQ: AKBA) flaunted slowness of -0.60% at $3.3, as the Stock market unbolted on Wednesday, before settling in for the price of
Akebia Therapeutics Inc (NASDAQ: AKBA) on Friday, soared 13.62% from the previous trading day, before settling in for the closing price of $3.01. Within the
Akebia Therapeutics Inc (NASDAQ: AKBA) on Tuesday, plunged -1.06% from the previous trading day, before settling in for the closing price of $3.76. Within the
Akebia Therapeutics Inc (NASDAQ: AKBA) kicked off on Tuesday, up 0.26% from the previous trading day, before settling in for the closing price of $3.84.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.